首页> 外文期刊>European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery >Various local hemostatic agents with different modes of action; an in vivo comparative randomized vascular surgical experimental study.
【24h】

Various local hemostatic agents with different modes of action; an in vivo comparative randomized vascular surgical experimental study.

机译:具有不同作用方式的各种局部止血剂;一项体内比较性随机血管外科实验研究。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To evaluate the effects of different local hemostatic agents in a new high flow vascular experimental bleeding model. DESIGN: Bovine thrombin combined with collagen matrix (bTcM), microporous polysaccharide hemospheres (MPH), freeze-dried rFVIIa with and without the combination of MPH were compared to a control group (solely compression) in a randomized fashion (20 animals/group). Primary endpoint was hemostasis, and secondary endpoints were time to hemostasis, blood loss, and blood pressure at hemostasis. METHODS: The common carotid artery of heparinized rats was ligated proximally and transected. Compression was applied for one minute followed by application of the topical hemostatic agent. Compression was maintained for another two minutes followed by re-evaluation of hemostasis: if bleeding continued additional compression was applied and thereafter bleeding was checked every minute until hemostasis. RESULTS: All animals in the bTcM group obtained hemostasis compared to 20% in the control group (p<0.0001). The combination of MPH and rFVIIa (70% hemostasis) also showed a significant hemostatic capacity compared to control group (p<0.001). None of the other active treatment groups differed compared to control group. Animals treated with bTcM had a significantly shorter time to hemostasis compared to animals in the other active treatment groups. No significant difference in blood loss and blood pressure at hemostasis was detected. CONCLUSIONS: The most effective hemostatic agent was bTcM, followed by the combination of rFVIIa and MPH, while neither MPH nor rFVIIa alone displayed any hemostatic capacity compared to compression only.
机译:目的:在新的高流量血管实验性出血模型中评估不同局部止血剂的作用。设计:将牛凝血酶联合胶原蛋白基质(bTcM),微孔多糖血球(MPH),冻干rFVIIa(含或不含MPH)与对照组(仅加压)进行了随机比较(每组20只动物) 。主要终点为止血,次要终点为止血时间,失血量和止血时的血压。方法:将肝素化大鼠的颈总动脉结扎并横断。加压一分钟,然后施加局部止血剂。保持压缩另外两分钟,然后重新评估止血:如果继续出血,则施加额外的压缩,此后每分钟检查一次出血直至止血。结果:bTcM组中的所有动物均具有止血作用,而对照组为20%(p <0.0001)。与对照组相比,MPH和rFVIIa的组合(止血率70%)也显示出显着的止血能力(p <0.001)。与对照组相比,其他所有积极治疗组均无差异。与其他活性治疗组的动物相比,bTcM治疗的动物的止血时间明显短得多。止血时的失血量和血压无明显差异。结论:最有效的止血剂是bTcM,然后是rFVIIa和MPH的组合,而与仅加压相比,单独的MPH和rFVIIa均未显示任何止血能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号